Aetos Pharma

Top Leading Sulodexide 250 LSU Capsules Manufacturer & Exporters in India

Aetos Pharma is a Sulodexide 250 LSU Capsules Manufacturer in India and also Exporters in the Latin American region including countries such as Bolivia, Ecuador, Dominican Republic, Chile, Venezuela, Brazil, Colombia, Mexico, Guyana, Guatemala, Panama, Trinidad and Tobago, and El Salvador.

Sulodexide 250 LSU Capsules Manufacturer, Exporter, and Supplier in India

Aetos Pharma is a pioneering pharmaceutical manufacturer committed to advancing healthcare solutions. We are delighted to present our latest innovation, the Sulodexide 250 LSU soft gel capsule. With a strong focus on quality, safety, and efficacy, our Sulodexide capsules stand at the forefront of vascular care, offering a transformative approach to managing various vascular disorders.

Comprehensive Vascular Management

Sulodexide demonstrates a multi-faceted mechanism of action, making it potent in the management of vascular disorders. Its benefits include:

Antithrombotic Action: By enhancing the activity of endogenous antithrombotic factors, Sulodexide reduces the risk of thrombus formation, thereby safeguarding against thrombotic events.
Anti-Inflammatory Properties: Sulodexide modulates the release of pro-inflammatory mediators, mitigating inflammation within blood vessels and promoting their normal function.
Vasoprotective Effects: By improving endothelial function and capillary permeability, Sulodexide enhances microcirculation and optimizes blood flow, offering protection to the vascular system.

Indications for Sulodexide 250 LSU Capsules

Our Sulodexide 250 LSU soft gel capsules are specifically indicated for the treatment of various vascular conditions, including:

– Chronic Venous Insufficiency (CVI): Sulodexide addresses the symptoms of CVI, such as leg swelling, varicose veins, and pain, by improving venous tone and microcirculation.

– Diabetic Nephropathy: The antithrombotic and vasoprotective properties of Sulodexide show promise in slowing the progression of diabetic nephropathy, safeguarding renal function in diabetic patients.

– Peripheral Arterial Disease (PAD): Sulodexide’s enhancement of endothelial function and blood flow proves beneficial in managing PAD, particularly in patients with intermittent claudication.

Unparalleled Formulation

The Sulodexide 250 LSU soft gel capsule boasts a unique formulation designed to optimize patient outcomes. With its easy-to-swallow soft gel casing, our capsules ensure enhanced patient compliance, easing the treatment process and improving adherence to therapy.

Safety and Quality Assurance

At Aetos Pharma, patient safety is our utmost priority. Our Sulodexide capsules undergo rigorous quality control measures, adhering to international standards and regulations. Through meticulous testing and validation, we guarantee a product of exceptional quality and safety.